Advances in the genetics and immunology of autoimmune polyglandular syndrome II/III and their clinical applications

Annales de Medecine Interne

Volumn 150, Issue 4, 1999, Pages 301-312

  Muir, Andrew ^a   She, Jin Xiong ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADRENAL CORTEX INSUFFICIENCY; AUTOIMMUNITY; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENOME; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE ENDOCRINE ADENOMATOSIS; PHENOTYPE; PROGNOSIS; REVIEW; THYROIDITIS;

ADDISON DISEASE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; AUTOANTIBODIES; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 22; GENES, RECESSIVE; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; IMMUNOCONJUGATES; PHENOTYPE; POLYENDOCRINOPATHIES, AUTOIMMUNE; THYROIDITIS, AUTOIMMUNE;

EID: 0032873646     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (113)

1. NAGAMINE K, PETERSON P, SCOTT H, et al.: Positional cloning of the APECED gene. Nature Genetics, 1997; 17: 393-8.
2. THE FINNISH GERMAN APECED CONSORTIUM: An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD type zinc finger domains. Nature Genetics, 1997; 17: 399-403.
3. NEUFELD M, MACLAREN NK, BLIZZARD R: Autoimmune polyglandular syndromes. Ped Ann, 1980; 9: 41:
4. NEUFELD M, MACLAREN NK, BLIZZARD RM: Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine, 1981; 60: 355-62.
5. AHONEN P, MYLLARNIEMI S, SIPILA I, PERHEENTUPA J: Clinical variation of autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med, 1990; 322: 1829-36.
6. SCHMIDT MB: Eine biglandulare Erkrankung (Nebennieren und Schilddrusse) bei Morbus Addisonii. Verh Dtsch Ges Pathol Ces, 1926; 21: 212-21.
7. CARPENTER CCJ, SOLOMON N, SILVERBERG SG, et al. Schmidt's syndrome (thyroid and adrenal insufficiency): A review of the literature and a report of fifteen new cases including ten instances of coexistent diabetes mellitus. Medicine, 1964; 43: 153-80.
8. RILEY WJ, MACLAREN NK: Autoimmune polyendocrinopathies: In: SAMTER M, TALMAGE DW, FRANK MM, et al., eds. Immunological Diseases. 4th ed. Boston: Little Brown, 1988: 1737-47.
9. KONG MF, JEFFCOATE W: Eighty six cases of Addison's disease. Clin Endocrinol, 1994; 41: 757-61.
10. WILLIS AC, VINCE FP: The prevalence of Addison's disease in Coventry, UK. Postgrad Med J, 1997; 73: 286-8.
11. JACOBSON DL, GANGE SJ, ROSE NR, GRAHAM NMH: Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol, 1997; 84: 223-43.
12. YAMAGUCHI Y, CHIKUBA N, UEDA Y, et al.: Islet cell antibodies in patients with autoimmune thyroid disease. Diabetes, 1991; 40: 319-22.
13. IRVINE WJ, MCCALLUM CJ, GRAY RS, et al: Pancreatic islet cell antibodies in diabetes mellitus correlatead with the duration and type of diabetes, coexistent autoimmune disease, and HLA type. Diabetes, 1977; 26: 138-47.
14. BETTERLE C, VOLPATO M, REES SMITH B, et al.: I. Adrenal cortex and steroid 21 hydroxylase autoantibodies in adult patients with organ specific autoimmune diseases: markers of low progression to clinical Addison's disease. J Clin Endocrinol Metab, 1997; 82: 932-8.
15. RILEY W, MACLAREN NK, LEZOTTE DC, et al.: Thyroid autoimmunity in insulin dependent diabetes mellitus: The case for routine screening. J Pediatr, 1981; 98: 350-4.
16. 35S-labeled recombinant human tyrosinase in a radioimmunoassay. J Invest Dermatol, 1997; 109: 69-73.
17. MANDRY RC, ORTIZ LJ, LUGO SOMOLINOS A, SANCHEZ JL: Organ specific autoantibodies in vitiligo patients and their relatives. Int J Dermatol, 1996; 35: 18-21.
18. WANG S, SHOHAT T, VADHEIM C, SHELLOW W, EDWARDS J, ROTTER JI: Increased risk for type I (insulin dependent) diabetes in relatiaves of patients with alopecia areata. Am J Med Gen, 1994; 51: 234-9.
19. MACLAREN N, RILEY W: Thyroid, gastric and adrenal autoimmunities and insulin dependent diabetes. Diabetes Care, 1985; 8: 34-8.
20. MARINO M, RICCIARDI R, PINCHERA A, et al.: Mild clinical expression of myasthenia gravis associated with autoimmune thyroid disease. J Clin Endocrinol Metab, 1997; 82: 438-43.
21. MARINO M, RICARDI R, PIHERA A, et al.: Mild clinical expression of myasthenia gravis associated with autoimmune thyroid disease. J Clin Endocrinol Metab, 1997; 82:438-43.
22. HANN SK, LEE HJ: Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol, 1996; 35: 671-4.
23. TUOMI T, GROOP LC, ZIMMET P, ROWLEY MJ, KNOWLES W, MACKAY IR: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non insulin dependent onset of disease. Diabetes, 1993; 42: 359-62.
24. KETCHUM C, RILEY W, MACLAREN N: Adrenal dysfunction in asymptomatic patients with adrenocortical autoantibodies. J Clin Endocrinol Metab, 1984; 58: 1166-70.
25. BETTERLE C, VOLPATO M, REES SMITH B, et al.: II. Adrenal cortex and steroid 21 hydroxylase autoantibodies in children with organ specific autoimmune diseases: markers of high progression to clinical Addison's disease. J Clin Endocrinol Metab, 1997; 82: 939-42.
26. LIBLAU RS, SINGER MS, MCDEVITT HO: Th1 and Th2 CD4+ T cells in the pathogenesis of organ specific autoimmune diseases. Immunol Today, 1995; 16: 34-8.
27. RABINOVITCH A: Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes, 1994; 43: 613-21.
28. PAUL WE, SEDER RA: Lymphocyte responses and cytokines. Cell, 1994; 16: 241-51.
29. BALASA B, DENG C, LEE J, et al.: Interferon gamma is necessary for the genesis of acetylcholine receptor induced clinical experimental autoimmune myasthenia gravis in mice. J Exp Med, 1997; 186: 385-91.
30. ASHTON-RICKARDT PG, BANDEIRA A, DELANY JR, et al.: Evidence for a differential avidity model of T cell selection in the thymus. Cell, 1994; 16: 651-63.
31. SEBZDA E, WALLACE VA, MAYER J, YEUNG RSM, MAK TW, OHASHI PS: Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science, 1994; 263: 1615-8.
32. SCHLOOT NC, ROEP BO, WEGMANN DR, YU L, WANG TB, EISENBARTH GS: T cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent onset IDDM, post onset IDDM patients and control subjects. Diabetologia, 1997; 40: 332-8.
33. ZHAO Z, GRANUCCI F, YEH L, SCHAFFER PA, CANTOR H: Molecular mimicry by herpes simplex virus type 1: autoimmune disease after viral infection. Science, 1998; 279: 1344-47.
34. BARTENEVA NS, EVSTAFIEVA AG, GORELOV VN, WENZEL BE: Identification and sequencing of a plasmid (pYV96) encoded gene product of Yersinia enterocolitica recognized by antibodies in sera of patients with autoimmune thyroid disease. Ann N Y Acad Sci, 1994; 730; 345-7.
35. PHILLIPS D, MCLACHLAN S, STEPHENSON A, et al.: Autosomal dominant transmission of autoantibodies to thyroglobulin and thyroid peroxidase. J Clin Endocrinol Metab, 1990; 70: 742-6.
36. PHILLIPS D, PRENTICE L, UPADHYAYA M, et al.: Autosomal dominant inheritance of autoantibodies to thyroid peroxidase and thyroglobulin-studies in families not selected for autoimmune thyroid disease. J Clin Endocrinol Metab, 1991; 72: 973-5.
37. PRENTICE L, PHILIPS D, PREMAWARDHANA LDKE, SMITH BR: Genetic linkage analysis of thyroid autoantibodies. Autoimmunity, 1993; 15: 225-9.
38. PHILIPS D, SHIELDS DC, DUGOUJON JM, PRENTICE L, MCGUFFIN P, SMITH BR: Complex segregation analysis of thyroid autoantibodies: Are they inherited as an autosomal dominant trait? Hum Hered, 1993; 43: 141-6.
39. PAULS DL, ZAKARIJA M, MAXWELL MCKENZIE J, EGELAND JA: Complex segregation analysis of antibodies to thyroid peroxidase in old order Amish families. Am J Med Genet, 1993; 47: 375-9.
40. SHE JX: Susceptibility to type I diabetes: HLA DQ and DR revisited. Immunol Today, 1996; 17: 323-9.
41. BADENHOOP K, SCHWARZ G, WALFISH PG, DRUMMOND V, USADEL KH, BOTTAZZO GF: Susceptibility to thyroid autoimmune disease: molecular analysis of HLA D region genes identifies new markers for goitous Hashimoto's thyroiditis. J Clin Endocrinol Metab, 1990; 71: 1131-37.
42. WAN XL, KIMURA A, DONG RP, HONDA K, TAMAI H, SASAZUKI T: HLA-A and DRB4 genes in controlling the susceptibility to Hashimoto's thyroiditis. Hum Immunol, 1995; 42: 131-6.
43. TAMAI H, KIMURA A, DONG RP, et al.: Resistence to autoimmune thyroid disease is associated with HLA DQ. J Clin Endocrinol Metab, 1994; 78: 94-7.
44. HUANG W, CONNOR E, DELA ROSA T, et al.: Although DR3 DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4 DQB1*0302 haplotype is implicated only in β-cell autoimmunity. J Clin Endocrinol Metab, 1996; 81: 2559-63.
45. YANAGAWA T, MANGKLABRUKS A, DEGROOT LJ: Strong association between HLA DQA1*0501 and Graves' disease in a male Caucasian population. J Clin Endocrinol Metab, 1994; 79: 227-9.
46. SANTAMARIA P, BARBOSA JJ, LINDSTROM AL, LEMKE TA, GOETZ FC, RICH SS: HLA-DQB1-associated susceptibility that distinguishes Hashimoto's thyroiditis from Graves's disease in type I diabetic patients. J Clin Endocrinol Metab, 1994; 78: 878-83.
47. PAYAMI H, JOE S, FARID NR, et al.: Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet, 1989; 45: 541-6.
48. BOEHM BO, KUHNL P, MANFRAS BJ, et al.: HLA-DRB3 gene alleles in Caucasian patients with Graves' disease. Mol Med, 1992; 70: 956-60.
49. MACLAREN NK, RILEY W: Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens DR3 and/or DR4, except when associated with type 1 autoimmune polyglandular syndrome. J Clin Endocrinol Metab, 1986; 62: 455-9.
50. WEETMAN AP, ZHANG L, TANDON N, EDWARDS OM: HLA associations with autoimmune Addison's disease. Tissue Antigens, 1991; 38: 31-3.
51. BOEHM BO, MANFRAS B, SEIDL S, et al.: The HLA-DQB non-Asp-57 allele: a predictor of future insulin-dependent diabetes mellitus in patients with autoimmune Addison's disease. Tissue Antigens, 1991; 37: 130-2.
52. DUNSTON GM, HAIDER RM: Vitiligo is associated with HLA-DR4 in black patients. Arch Dermatol, 1990; 126: 56-60.
53. DJABIRI F, CAILLAT ZUCMAN S, GAJDOS P, et al.: Association of the AChRα subunit gene DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three gene disease model in a subgroup of patients. J Autoimmun, 1997; 10: 407-13.
54. BADENHOOP K, WALFISH PG, RAU H, et al.: Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab, 1995; 80: 2112-7.
55. YANAGAWA T, HIDAKA Y, GUIMARACS V, SOLIMAN M, DEGROOT LJ: CTLA4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab, 1995; 80: 41-5.
56. NISTICO L, BUZZETTI R, PRITCHARD LE, et al.: The CTLA4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet, 1996; 5: 1075-80.
57. DONNER H, RAU H, WALFISH PG, et al.: CTLA4 alanine 17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab, 1997; 82: 143-6.
58. MARRON MP, RAFFEL LJ, GARCHON H-J, et al.: Insulin dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet, 1997; 8: 1275-82.
59. AWATA T, KURIHARA S, IITAKA M, et al.: Association of CTLA4 gene A G polymorphism (IDDM12 locus) with acute onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes, 1998; 47: 128-9.
60. DONNER H, BRAUN J, SEIDL C, et al.: Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab, 1997; 82: 4130-2.
61. MANGKLABRUSKS A, COX N, DEGROOT LJ: Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J Clin Endocrinol Metab, 1991; 73: 236-44.
62. DAVIES JL, YOSHIHIKO K, BENNETT S, et al.: A genome wide search for human type 1 diabetes susceptibility genes. Nature, 1994; 371: 130-6.
63. HASHIMOTO L, HABITA C, BERESSI JP, et al.: Genetic mapping of a susceptibility locus for insulin dependent diabetes mellitus on chromosome 11q. Nature, 1994; 371: 161-4.
64. FIELD LL, TOBIAS R, MAGNUS T: A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin-dependent diabetes mellitus. Nat Genet, 1994; 8: 189-94.
65. LUO DF, BUI MM, MUIR A, MACLAREN NK, THOMSON G, SHE JX: Affected sibpair mapping of a novel susceptibility gene to insulin dependent diabetes mellitus (IDDM8) on chromosome 6q25 q27. Am J Hum Genet, 1995; 57: 911-9.
66. MORAHAN G, HUANG D, TAIT BD, COLMAN PG, HARRISON LC: Markers on distal chromosome 2q linked to insulin dependent diabetes mellitus. Science, 1996; 272: 1811-3.
67. DELEPINE M, POCIOT F, HABITA C, et al.: Evidence of a non MHC susceptibility locus in type I diabetes linked to HLA on chromosome 6. Am J Hum Genet, 1997; 60: 174-87.
68. FIELD LL, TOBIAS R, THOMSON G, PLON S: Susceptibility to insulin dependent diabetes mellitus maps to a locus (IDDM11) on human chromosome 14q24.3 q31. Genomics, 1996; 33: 1-8.
69. TOMER Y, BARBESINO G, KEDDACHE M, GREENBERG D, DAVIES TF: Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31. J Clin Endocrinol Metab, 1997; 82: 1645-8.
70. SONG YH, CONNOR E, LI Y, ZOROVICH B, BALDUCCI P, MACLAREN N: The role of tyrosinase in autoimmune vitiligo. Lancet, 1994; 344: 1049-52.
71. KEMP EH, GAWKRODGER DJ, WATSON PF, WEETMAN AP: Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase related protein 2. Clin Exp Immunol, 1997; 109: 495-500.
72. BAHARAV E, MERIMSKI O, SHOENFELD Y, ZIGELMAN R, GILBRUND B, YECHESKEL G: Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol, 1996; 105: 84-8.
73. HOEK A, SCHOEMAKER J, DREXHAGE HA: Premature ovarian failure and ovarian autoimmunity. Endocrine Rev, 1997; 18: 107-34.
74. ALDERUCCIO F, GLEESON PA, BERZINS SP, MARTIN M, VANDRIEL IR, TOH BH: Expression of the gastric H/K-ATPase alpha subunit in the thymus may explain the dominant role of the beta subunit in the pathogenesis of autoimmune gastritis. Autoimmunity, 1997; 25: 167-75.
75. NAVANEETHAM D, PENN A, HOWARD JJ, CONTI FINE BM: Expression of the alpha 7 subunit of the nicotinic acetylcholine receptor in normal and myasthenie human thymuses. Cell Mol Biol, 1997; 43: 433-42.
76. PUGLIESE A, ZELLER M, FERNANDEZ AJ, et al.: The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nature Genet 1997; 15: 293-7.
77. VAFIADIS P, BENNETT ST, TODD JA, et al.: Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nature Genet, 1997; 15: 289-92.
78. ZIMMER KP, SCHEUMANN GF, BRAMSWIG J, BOCKER W, HARMS E, SCHMID KW: Ultrastructural localization of IgG and TPO in autoimmune thyrocytes referring to the transcytosis of IgG and the antigen presentation of TPO. Histochem Cell Biol, 1997; 107: 115-20.
79. GUO J, JAUME JC, RAPOPORT B, MCLACHLAN SM: Recombinant thryoid peroxidase specific Fab converted to immunoglobulin G molecules: evidence for thyroid cell damage by IgG1, but not IgG4, autoantibodies. J Clin Endocrinol Metab, 1997; 82: 925-31.
80. MUIR A, PECK A, CLARE SALZLER M, et al.: Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon gamma transcription. J Clin Invest, 1995; 95: 628-34.
81. RAMIYA VK, SHANG X, PHARIS PG, et al.: Antigen based therapies to prevent diabetes in NOD mice. J Autoimmun, 1996; 9: 349-56.
82. WU B, DENG C, GOLUSZKO E, CHRISTADOSS P: Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces eptiope spread and supresses murine myasthenia gravis. J Immunol, 1997; 159: 3016-23.
83. LIBLAU R, TISCH R, BERCOVICI N, MCDEVITT HO: Systemic antigen in the treatment of T-cell-mediated autoimmune diseases. Immunol Today, 1997; 18: 599-604.
84. POLANSKI M, MELICAN NS, ZHANG J, WEINER HL: Oral administration of the immunodominant B chain of insulin reduces diabetes in a co transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines. J Autoimmun, 1997; 10: 339-46.
85. MILLER A, AL SABBAGH A, SANTOS LMB, DAS MP, WEINER HL: Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope driven bystander suppression. J Immunol, 1993; 151(12): 7307-15.
86. CETKOVIC-CVRLJE M, GERLING IC, MUIR A, ATKINSON MA, ELLIOTT JF, LEITER EH: Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate β-cell antigens. Diabetes, 1997; 46: 1975-82.
87. ARSCOTT PL, KOENIG RJ, KAPLAN MM, GLICK GD, BAKER JRJ: Unique autoantibody epitopes in an immunodominant region of thyroid peroxidase. J Biol Chem, 1996; 271: 4966-73.
88. CARAYANNIOTIS G, RAO VP: Searching for pathogenic epitopes in thyroglobulin: parameters and caveats. Immunol Today, 1997; 18: 83-8.
89. CONRAD B, WEISSMAHR RN, BONI J, ARCARI R, SCHUPBACH J, MACH B: A human endogeneous retroviral superantigen as candidate autoimmune gene in type 1 diabetes. Cell, 1997; 90: 303-13.
90. YU L, REWERS M, GIANANI R, et al.: Antiislet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab, 1996; 81: 4264-7.
91. YAMAGATA K, NAKAJIMA H, TOMITA K, et al.: Dominant TCR alpha chain clonotypes and interferon gamma are expressed in the pancreas of patients with recent onset insulin dependent diabetes mellitus. Diabetes Res Clin Pract, 1996; 34: 37-46.
92. MCINTOSH RS, WATSON PF, WEETMAN AP: Analysis of the T cell receptor V alpha repertoire in Hashimoto's thyroiditis: evidence fro the restricted accumulation of CD8+ T cells in the absence of CD4+ T cell restriction. J Clin Endocrinol Metab, 1997; 82: 1140-6.
93. DAVIES TF, MARTIN A, CONCEPCION ES, GRAVES P, COHEN L, BEN-NUN A: Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N Engl J Med, 1991; 325: 238-44.
94. MUIR A, SCHATZ D, MACLAREN NK: Autoimmune Addison's disease. Immunopathology, 1993; 14: 275-84.
95. FALORNI A, LAURETI S, NIKOSHKOV A, et al.: 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Clin Exp Immunol, 1997; 107: 341-6.
96. TANAKA H, PEREZ MS, POWELL M, et al.: Steroid 21 hydroxylase autoantibodies: measurements with a new immunoprecipitation assay. J Clin Endocrinol Metab, 1997; 82: 1440-46.
97. SONG YH, CONNOR EL, MUIR A, et al.: Autoantibody epitope mapping of the 21-hydroxylase antigen in autoimmune Addison disease. J Clin Endocrinol Metab, 1994; 78: 1108-12.
98. SODERBERGH A, WINQVIST O, NORHEIM I, et al.: Adrenal autoantibodies and organ specific autoimmunity in patients with Addison's disease. Clin Endocrinol Oxf, 1996; 45: 453-60.
99. PETERSON P, UIBO R, PERANEN J, KROHN K: Immunoprecipitation of steroidogenic enzyme autoantigens with autoimmune polyglandular syndrome type I (APS I) sera; further evidence for independent humoral immunity to P450c17 and P450c21. Clin Exp Immunol, 1997; 107; 335-40.
100. ELDER M, MACLAREN N, RILEY W: Gonadal antibodies in patients with hypogonadism and/or Addison's disease. J Clin Endocrinol Metab, 1981; 52: 1137-42.
101. WINQVIST O, GEBRE MEDHIN G, GUSTAFSSON J, et al.: Identification of the main gonadal autoantigens in patients with adrenal insufficiency and associated ovarian failure. J Clin Endocrinol Metab, 1995; 80: 1502-5.
102. AHONEN P, MEITTINEN A, PERHEENTUPA J: Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type 1 and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab, 1987; 64: 494-500.
103. ROSE NR, WITEBSKY E: Studies on organ specificity: V. Changes in the thyroid gland of rabbits following active immunization with rabbit thyroid extracts. J Immunol, 1956; 76: 417-27.
104. BERNARD CCA, MANDEL TE, MACKAY IR: Experimental Models of Human Autoimmune Disease: Overview and Prototypes. In: ROSE NR, MACKAY IR, eds. The Autoimmune Diseases II. 2nd ed. New York: Academic Press Inc, 1992: 47-89.
105. CZARNOCKA B, RUF J, FERRAND M, CARAYON P, LISSITZKY S: Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett, 1985; 190: 147-52.
106. LORINI R, D'ANNUNZIO G, VITALI L, SCARAMUZZA A: IDDM and autoimmune thyroid disease in the pediatric age group. J Pediatr Endocrinol Metab, 1996; 9: 89-94.
107. WEETMAN AP, MCGREGOR AM: Autoimmune thyroid disease: further developments in our understanding. Endocrine Rev, 1994; 15: 788-830.
108. SALVI M, BERNARD M, MILLER A, ZHANG Z, GARDINI E, WALL JR: Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid associated ophthalmopathy. Thyroid, 1991; 1: 207-13.
109. HOUSE D, WINTER WE: Autoimmune diabetes: The role of autoantibody markers in the prediction and prevention of insulin dependent diabetes mellitus. Clin Lab Med, 1997; 17: 499-545.
110. ATKINSON MA, MACLAREN NK: Islet cell autoantigens in insulin dependent diabetes. J Clin Invest, 1993; 92: 1608-16.
111. SIMONE E, EISENBARTH GS: Chronic autoimmunity of type I diabetes. Horm Metab Res, 1996; 28: 332-6.
112. SCHLOOT NC, ROEP BO: Islet antigen specific T cell clones in autoimmune diabetes: from mice to men. Diabetes Metab Rev, 1997; 13: 127-38.
113. TISCH R, MCDEVITT H: Insulin-dependent diabetes mellitus. Cell, 1996; 85: 291-7.